Format

Send to

Choose Destination
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Mar 10;37(3):277-283. doi: 10.3760/cma.j.issn.1003-9406.2020.03.009.

[Clinical practice guidelines for polycystic kidney diseases].

[Article in Chinese]

Author information

1
Department of Nephrology, Changzheng Hospital, Naval Medical University, Shanghai 200003, China. changlinmei@smmu.edu.cn.

Abstract

Polycystic kidney disease (PKD) is a group of hereditary kidney diseases caused by genetic mutations. Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD) are the two main forms of PKD. The pathological features of PKD include progressive enlargement of renal cysts and destruction of kidney structure, which may eventually lead to end-stage renal disease (ESRD). As a result, the lives of PKD patients can only be sustained by dialysis or kidney transplantation. On the basis of basic research, clinical studies and guidelines issued for PKD at home and abroad, and by combining with the reality of Chinese PKD patients, this guideline has summarized the key points for the genetic counseling and clinical treatment of PKD, with an aim to improve the understanding and standardized diagnosis and treatment for such disorders.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center